| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 SPOCK1 CAPS PCDHB6 PCDHAC2 CDH23 PCDH17 ITPR3 MYOF CDH24 CELSR1 CDH20 VCAN PCDH19 DSG4 FER1L5 CDH5 HSPA5 RAB11FIP3 | 8.91e-07 | 749 | 137 | 19 | GO:0005509 |
| GeneOntologyMolecularFunction | protein serine kinase activity | HIPK4 TRPM7 RPS6KA2 STK31 STK3 CLK1 CLK2 CDK13 NEK8 DCLK3 MAPK7 | 4.23e-05 | 363 | 137 | 11 | GO:0106310 |
| GeneOntologyMolecularFunction | protein kinase activity | HIPK4 TRPM7 RPS6KA2 STK31 STK3 CLK1 CLK2 CDK13 NEK8 DCLK3 ROS1 MAPK7 EPHA1 EPHB1 | 6.68e-05 | 600 | 137 | 14 | GO:0004672 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | HIPK4 TRPM7 RPS6KA2 STK31 STK3 CLK1 CLK2 CDK13 NEK8 DCLK3 ROS1 MAPK7 ADPGK EPHA1 EPHB1 | 1.09e-04 | 709 | 137 | 15 | GO:0016773 |
| GeneOntologyMolecularFunction | telomeric repeat-containing RNA binding | 1.40e-04 | 3 | 137 | 2 | GO:0061752 | |
| GeneOntologyMolecularFunction | NACHT domain binding | 1.40e-04 | 3 | 137 | 2 | GO:0032089 | |
| GeneOntologyMolecularFunction | kinase activity | HIPK4 TRPM7 RPS6KA2 STK31 STK3 CLK1 CLK2 CDK13 NEK8 DCLK3 ROS1 MAPK7 ADPGK EPHA1 EPHB1 | 2.45e-04 | 764 | 137 | 15 | GO:0016301 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | HIPK4 TRPM7 RPS6KA2 STK31 STK3 CLK1 CLK2 CDK13 NEK8 DCLK3 MAPK7 | 2.59e-04 | 446 | 137 | 11 | GO:0004674 |
| GeneOntologyMolecularFunction | RNA strand annealing activity | 4.61e-04 | 5 | 137 | 2 | GO:0033592 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 4.98e-04 | 145 | 137 | 6 | GO:0004713 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | HIPK4 TRPM7 RPS6KA2 PIGG STK31 STK3 CLK1 CLK2 CDK13 NEK8 DCLK3 ROS1 MAPK7 ADPGK EPHA1 EPHB1 | 7.12e-04 | 938 | 137 | 16 | GO:0016772 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 PCDHB6 PCDHAC2 CDH23 PCDH17 CNTN6 CDH24 CELSR1 CDH20 PCDH19 DSG4 CDH5 | 3.48e-09 | 187 | 134 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 PCDHB6 PCDHAC2 CDH23 PCDH17 CNTN6 CDH24 CELSR1 CDH20 PCDH19 DSG4 MAPK7 CDH5 | 1.35e-07 | 313 | 134 | 13 | GO:0098742 |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 2.19e-05 | 9 | 134 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 2.40e-05 | 53 | 134 | 5 | GO:0016339 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 2.35e-05 | 9 | 139 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | catenin complex | 5.83e-05 | 32 | 139 | 4 | GO:0016342 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 9.93e-05 | 14 | 139 | 3 | GO:0072379 | |
| Domain | Cadherin_CS | DCHS2 PCDHB6 PCDHAC2 CDH23 PCDH17 CDH24 CELSR1 CDH20 PCDH19 DSG4 CDH5 | 5.36e-10 | 109 | 139 | 11 | IPR020894 |
| Domain | CADHERIN_1 | DCHS2 PCDHB6 PCDHAC2 CDH23 PCDH17 CDH24 CELSR1 CDH20 PCDH19 DSG4 CDH5 | 7.92e-10 | 113 | 139 | 11 | PS00232 |
| Domain | Cadherin | DCHS2 PCDHB6 PCDHAC2 CDH23 PCDH17 CDH24 CELSR1 CDH20 PCDH19 DSG4 CDH5 | 7.92e-10 | 113 | 139 | 11 | PF00028 |
| Domain | CADHERIN_2 | DCHS2 PCDHB6 PCDHAC2 CDH23 PCDH17 CDH24 CELSR1 CDH20 PCDH19 DSG4 CDH5 | 8.71e-10 | 114 | 139 | 11 | PS50268 |
| Domain | - | DCHS2 PCDHB6 PCDHAC2 CDH23 PCDH17 CDH24 CELSR1 CDH20 PCDH19 DSG4 CDH5 | 8.71e-10 | 114 | 139 | 11 | 2.60.40.60 |
| Domain | CA | DCHS2 PCDHB6 PCDHAC2 CDH23 PCDH17 CDH24 CELSR1 CDH20 PCDH19 DSG4 CDH5 | 9.57e-10 | 115 | 139 | 11 | SM00112 |
| Domain | Cadherin-like | DCHS2 PCDHB6 PCDHAC2 CDH23 PCDH17 CDH24 CELSR1 CDH20 PCDH19 DSG4 CDH5 | 1.05e-09 | 116 | 139 | 11 | IPR015919 |
| Domain | Cadherin | DCHS2 PCDHB6 PCDHAC2 CDH23 PCDH17 CDH24 CELSR1 CDH20 PCDH19 DSG4 CDH5 | 1.26e-09 | 118 | 139 | 11 | IPR002126 |
| Domain | DUF2012 | 1.60e-06 | 4 | 139 | 3 | PF09430 | |
| Domain | DUF2012 | 1.60e-06 | 4 | 139 | 3 | IPR019008 | |
| Domain | HSP70_2 | 6.49e-06 | 17 | 139 | 4 | PS00329 | |
| Domain | HSP70_1 | 6.49e-06 | 17 | 139 | 4 | PS00297 | |
| Domain | HSP70_3 | 6.49e-06 | 17 | 139 | 4 | PS01036 | |
| Domain | Hsp_70_fam | 8.29e-06 | 18 | 139 | 4 | IPR013126 | |
| Domain | Carb-bd-like_fold | 2.20e-05 | 8 | 139 | 3 | IPR013784 | |
| Domain | Protein_kinase_ATP_BS | HIPK4 RPS6KA2 STK3 CLK1 CLK2 CDK13 NEK8 DCLK3 ROS1 MAPK7 EPHA1 EPHB1 | 2.70e-05 | 379 | 139 | 12 | IPR017441 |
| Domain | Cadherin_C | 3.29e-05 | 25 | 139 | 4 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 3.29e-05 | 25 | 139 | 4 | IPR000233 | |
| Domain | PROTEIN_KINASE_ATP | HIPK4 RPS6KA2 STK31 STK3 CLK1 CLK2 CDK13 NEK8 DCLK3 ROS1 MAPK7 EPHA1 EPHB1 | 3.94e-05 | 459 | 139 | 13 | PS00107 |
| Domain | Kinase-like_dom | HIPK4 TRPM7 RPS6KA2 STK31 STK3 CLK1 CLK2 CDK13 NEK8 DCLK3 ROS1 MAPK7 EPHA1 EPHB1 | 5.36e-05 | 542 | 139 | 14 | IPR011009 |
| Domain | Catenin_binding_dom | 6.04e-05 | 29 | 139 | 4 | IPR027397 | |
| Domain | - | 6.04e-05 | 29 | 139 | 4 | 4.10.900.10 | |
| Domain | FN3 | 7.43e-05 | 185 | 139 | 8 | SM00060 | |
| Domain | Prot_kinase_dom | HIPK4 RPS6KA2 STK31 STK3 CLK1 CLK2 CDK13 NEK8 DCLK3 ROS1 MAPK7 EPHA1 EPHB1 | 7.51e-05 | 489 | 139 | 13 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | HIPK4 RPS6KA2 STK31 STK3 CLK1 CLK2 CDK13 NEK8 DCLK3 ROS1 MAPK7 EPHA1 EPHB1 | 8.15e-05 | 493 | 139 | 13 | PS50011 |
| Domain | CarboxyPept_regulatory_dom | 1.09e-04 | 13 | 139 | 3 | IPR014766 | |
| Domain | - | 1.09e-04 | 13 | 139 | 3 | 2.60.40.1120 | |
| Domain | - | FLNB FLNC COL7A1 FSD1 CNTN6 NOMO1 SEMA4C PTPRK BTNL3 NOMO2 VCAN ROS1 NOMO3 EPHA1 EPHB1 | 1.27e-04 | 663 | 139 | 15 | 2.60.40.10 |
| Domain | FerA | 1.64e-04 | 3 | 139 | 2 | SM01200 | |
| Domain | Ferlin_A-domain | 1.64e-04 | 3 | 139 | 2 | IPR012560 | |
| Domain | HnRNPA1 | 1.64e-04 | 3 | 139 | 2 | IPR021662 | |
| Domain | FerA | 1.64e-04 | 3 | 139 | 2 | PF08165 | |
| Domain | HnRNPA1 | 1.64e-04 | 3 | 139 | 2 | PF11627 | |
| Domain | FN3_dom | 1.73e-04 | 209 | 139 | 8 | IPR003961 | |
| Domain | fn3 | 2.12e-04 | 162 | 139 | 7 | PF00041 | |
| Domain | Ig-like_fold | FLNB FLNC COL7A1 FSD1 CNTN6 NOMO1 SEMA4C PTPRK BTNL3 NOMO2 VCAN ROS1 NOMO3 EPHA1 EPHB1 | 2.51e-04 | 706 | 139 | 15 | IPR013783 |
| Domain | CarboxyPept-like_regulatory | 2.54e-04 | 17 | 139 | 3 | IPR008969 | |
| Domain | - | 3.03e-04 | 18 | 139 | 3 | 3.30.470.20 | |
| Domain | DysFC | 3.27e-04 | 4 | 139 | 2 | SM00694 | |
| Domain | DysFN | 3.27e-04 | 4 | 139 | 2 | SM00693 | |
| Domain | Peroxin/Ferlin | 3.27e-04 | 4 | 139 | 2 | IPR006614 | |
| Domain | Ser/Thr_kinase_AS | 3.45e-04 | 357 | 139 | 10 | IPR008271 | |
| Domain | S_TKc | 3.61e-04 | 359 | 139 | 10 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 3.85e-04 | 362 | 139 | 10 | PS00108 | |
| Domain | FerI | 5.42e-04 | 5 | 139 | 2 | SM01202 | |
| Domain | FerB | 5.42e-04 | 5 | 139 | 2 | SM01201 | |
| Domain | Ferlin_B-domain | 5.42e-04 | 5 | 139 | 2 | IPR012561 | |
| Domain | Ferlin_C | 5.42e-04 | 5 | 139 | 2 | PF16165 | |
| Domain | Ferlin_C | 5.42e-04 | 5 | 139 | 2 | IPR032362 | |
| Domain | FerIin_dom | 5.42e-04 | 5 | 139 | 2 | IPR012968 | |
| Domain | FerI | 5.42e-04 | 5 | 139 | 2 | PF08151 | |
| Domain | FerB | 5.42e-04 | 5 | 139 | 2 | PF08150 | |
| Domain | Pkinase | 5.74e-04 | 381 | 139 | 10 | PF00069 | |
| Domain | FN3 | 7.32e-04 | 199 | 139 | 7 | PS50853 | |
| Domain | RBD-FIP | 8.09e-04 | 6 | 139 | 2 | PF09457 | |
| Domain | FAD-bd | 8.09e-04 | 6 | 139 | 2 | IPR002938 | |
| Domain | FAD_binding_3 | 8.09e-04 | 6 | 139 | 2 | PF01494 | |
| Domain | Rab-bd_FIP-RBD | 8.09e-04 | 6 | 139 | 2 | IPR019018 | |
| Domain | FIP_RBD | 8.09e-04 | 6 | 139 | 2 | PS51511 | |
| Domain | ConA-like_dom | 1.28e-03 | 219 | 139 | 7 | IPR013320 | |
| Domain | Cadherin_2 | 1.40e-03 | 65 | 139 | 4 | PF08266 | |
| Domain | Cadherin_N | 1.40e-03 | 65 | 139 | 4 | IPR013164 | |
| Domain | GPCR_3_mtglu_rcpt | 1.50e-03 | 8 | 139 | 2 | IPR000162 | |
| Domain | ATP_grasp_subdomain_2 | 1.56e-03 | 31 | 139 | 3 | IPR013816 | |
| Domain | IG_FLMN | 2.38e-03 | 10 | 139 | 2 | SM00557 | |
| Domain | Filamin | 2.89e-03 | 11 | 139 | 2 | PF00630 | |
| Domain | FILAMIN_REPEAT | 2.89e-03 | 11 | 139 | 2 | PS50194 | |
| Domain | Filamin/ABP280_rpt | 2.89e-03 | 11 | 139 | 2 | IPR001298 | |
| Domain | Filamin/ABP280_repeat-like | 2.89e-03 | 11 | 139 | 2 | IPR017868 | |
| Domain | - | 3.46e-03 | 12 | 139 | 2 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 3.46e-03 | 12 | 139 | 2 | IPR029047 | |
| Domain | PRY | 3.75e-03 | 42 | 139 | 3 | PF13765 | |
| Domain | SPRY | 4.06e-03 | 87 | 139 | 4 | SM00449 | |
| Domain | HTH_Tnp_Tc5 | 4.06e-03 | 13 | 139 | 2 | PF03221 | |
| Domain | - | 4.06e-03 | 13 | 139 | 2 | 1.20.1270.10 | |
| Domain | NCD3G | 4.06e-03 | 13 | 139 | 2 | PF07562 | |
| Domain | Heat_shock_70_CS | 4.06e-03 | 13 | 139 | 2 | IPR018181 | |
| Domain | HSP70_C | 4.06e-03 | 13 | 139 | 2 | IPR029048 | |
| Domain | GPCR_3_9-Cys_dom | 4.06e-03 | 13 | 139 | 2 | IPR011500 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 4.72e-03 | 14 | 139 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 4.72e-03 | 14 | 139 | 2 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 4.72e-03 | 14 | 139 | 2 | IPR001426 | |
| Domain | EphA2_TM | 4.72e-03 | 14 | 139 | 2 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 4.72e-03 | 14 | 139 | 2 | IPR001090 | |
| Domain | Eph_TM | 4.72e-03 | 14 | 139 | 2 | IPR027936 | |
| Domain | EPH_lbd | 4.72e-03 | 14 | 139 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 4.72e-03 | 14 | 139 | 2 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 4.72e-03 | 14 | 139 | 2 | IPR016257 | |
| Domain | EPH_LBD | 4.72e-03 | 14 | 139 | 2 | PS51550 | |
| Domain | GPCR_3_CS | 4.72e-03 | 14 | 139 | 2 | IPR017979 | |
| Domain | SPRY | 5.34e-03 | 94 | 139 | 4 | PF00622 | |
| Domain | SPRY_dom | 5.34e-03 | 94 | 139 | 4 | IPR003877 | |
| Domain | Galactose-bd-like | 5.34e-03 | 94 | 139 | 4 | IPR008979 | |
| Domain | PRY | 5.46e-03 | 48 | 139 | 3 | SM00589 | |
| Domain | PRY | 5.46e-03 | 48 | 139 | 3 | IPR006574 | |
| Domain | B30.2/SPRY | 5.54e-03 | 95 | 139 | 4 | IPR001870 | |
| Domain | B302_SPRY | 5.54e-03 | 95 | 139 | 4 | PS50188 | |
| Domain | IBN_N | 6.16e-03 | 16 | 139 | 2 | SM00913 | |
| Domain | HSP70 | 6.16e-03 | 16 | 139 | 2 | PF00012 | |
| Domain | Sushi | 6.83e-03 | 52 | 139 | 3 | PF00084 | |
| Pubmed | 6.38e-08 | 3 | 140 | 3 | 36011023 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 6.38e-08 | 3 | 140 | 3 | 25576386 | |
| Pubmed | FLNB FLNC ACLY LRRC49 NIPSNAP1 PHB2 HNRNPA1L2 GRM1 GTPBP1 GRM3 HNRNPA1 NDUFS2 HSPA12A NWD2 VCAN SMU1 MICAL3 PC METAP2 HSPA5 HSPA9 CACNA2D3 | 6.85e-08 | 1431 | 140 | 22 | 37142655 | |
| Pubmed | 8.87e-08 | 191 | 140 | 9 | 33762435 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | RPS6KA2 PTER PAICS NOMO1 TRIM16 STK3 MYOF NOMO2 CLK1 CLK2 CDK13 PRKAR1B MAPK7 METAP2 HSPA5 HSPA9 NOMO3 | 1.68e-07 | 910 | 140 | 17 | 36736316 |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 2.55e-07 | 4 | 140 | 3 | 31833031 | |
| Pubmed | 2.55e-07 | 4 | 140 | 3 | 9267806 | ||
| Pubmed | FLNB FLNC ACLY PAICS ITPR3 TRIM16 MICAL3 PC METAP2 HSPA9 DYNC1I2 | 2.59e-07 | 360 | 140 | 11 | 33111431 | |
| Pubmed | ACLY HNRNPA1L2 HNRNPA1 PAICS NDUFS2 NOMO1 SLC6A6 HSPA12A NOMO2 HSPA5 HSPA9 NOMO3 DYNC1I2 | 4.04e-07 | 552 | 140 | 13 | 36293380 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | TMED1 FLNB FLNC ACLY DHX40 HNRNPA1L2 PAICS NOMO1 ITPR3 PTPRK XPO5 AGL ASNS SMU1 TXNDC9 TTC13 HSPA5 | 4.32e-07 | 974 | 140 | 17 | 28675297 |
| Pubmed | 6.35e-07 | 5 | 140 | 3 | 12006559 | ||
| Pubmed | FLNB FLNC COQ6 PHB2 HNRNPA1 PAICS NOMO1 MYOF ASNS HSPA5 HSPA9 | 6.79e-07 | 397 | 140 | 11 | 21319273 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | FLNB ERCC6 ACLY BTBD10 PHB2 LAMA3 YBX3 GTPBP1 HNRNPA1 PAICS NDUFS2 ITPR3 MYOF DDX50 SMU1 METAP2 HSPA5 HSPA9 RSBN1L | 7.59e-07 | 1257 | 140 | 19 | 36526897 |
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | FLNB ACLY HDAC8 PHB2 YBX3 BTBD9 PAICS AGL TXNDC9 TACC3 HSPA5 HSPA9 | 8.50e-07 | 495 | 140 | 12 | 28581483 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLNB ACLY NIPSNAP1 PHB2 YBX3 GRM1 GTPBP1 HNRNPA1 PAICS NDUFS2 NOMO1 MRM3 DDX50 XPO5 ASNS SMU1 BOD1L1 PC HSPA5 HSPA9 | 1.19e-06 | 1425 | 140 | 20 | 30948266 |
| Pubmed | FLNB ACLY COQ6 NIPSNAP1 PIGG RAB11FIP1 HNRNPA1 PAICS MYOF DDX50 XPO5 NOMO2 BOD1L1 TTC13 CTSL METAP2 HSPA5 HSPA9 ADPGK | 1.21e-06 | 1297 | 140 | 19 | 33545068 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 1.45e-06 | 344 | 140 | 10 | 30333137 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | TMED1 COL7A1 SPOCK1 ACLY B3GALNT2 PIGG PAICS DMXL1 NOMO1 SLC6A6 MYOF CELSR1 PTPRK NOMO2 TTC13 CTSL HSPA5 ADPGK | 1.72e-06 | 1201 | 140 | 18 | 35696571 |
| Pubmed | 2.24e-06 | 146 | 140 | 7 | 29509794 | ||
| Pubmed | TRPM7 NIPSNAP1 PHB2 RAB11FIP1 HSPA12B HNRNPA1 NDUFS2 DMXL1 NOMO1 ITPR3 HSPA12A TIMM21 NOMO2 ASNS SMU1 PRKAR1B TTC13 IFT80 HSPA5 HSPA9 | 2.27e-06 | 1487 | 140 | 20 | 33957083 | |
| Pubmed | CDK7/GRP78 signaling axis contributes to tumor growth and metastasis in osteosarcoma. | FLNB FLNC NIPSNAP1 PHB2 HNRNPA1 MYOF TRAK2 PC HSPA5 HSPA9 DYNC1I2 | 3.33e-06 | 468 | 140 | 11 | 36042349 |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | FLNB TRPS1 PHB2 YBX3 HNRNPA1 PAICS NOMO1 MRM3 DDX50 CDK13 MICAL3 NOMO3 DYNC1I2 | 3.44e-06 | 670 | 140 | 13 | 22990118 |
| Pubmed | Nicalin and its binding partner Nomo are novel Nodal signaling antagonists. | 3.52e-06 | 8 | 140 | 3 | 15257293 | |
| Pubmed | 3.80e-06 | 58 | 140 | 5 | 30009671 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | FLNB FLNC ACLY PHB2 HNRNPA1 PAICS ASNS TACC3 HSPA5 HSPA9 DYNC1I2 | 3.99e-06 | 477 | 140 | 11 | 31300519 |
| Pubmed | Substrate-driven assembly of a translocon for multipass membrane proteins. | 5.27e-06 | 9 | 140 | 3 | 36261522 | |
| Pubmed | FLNB FLNC SPOCK1 COQ6 EML6 PHB2 YBX3 HNRNPA1L2 STK31 HNRNPA1 TRIM16 DDX50 SLC12A4 TIMM21 CDK13 BOD1L1 HSPA5 HSPA9 DYNC1I2 | 5.61e-06 | 1442 | 140 | 19 | 35575683 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 5.82e-06 | 316 | 140 | 9 | 31665637 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | WWP1 COQ6 PHB2 PCDHAC2 NDUFS2 SEMA4C TRIM16 SLC6A6 MYOF SLC12A4 XPO5 PC HSPA5 HSPA9 ADPGK IPO11 | 6.25e-06 | 1061 | 140 | 16 | 33845483 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TMED1 GALC ZNF143 NIPSNAP1 PHB2 CDH23 RAB11FIP1 NPHP4 NDUFS2 NOMO1 STK3 XPO5 NEK8 SMU1 IFT80 HSPA5 DYNC1I2 IPO11 | 6.41e-06 | 1321 | 140 | 18 | 27173435 |
| Pubmed | 6.69e-06 | 65 | 140 | 5 | 34645483 | ||
| Pubmed | MKKS NDUFS2 NOMO1 STK3 NOMO2 AGL PJA1 MTO1 PC ADPGK NOMO3 IPO11 | 6.77e-06 | 606 | 140 | 12 | 36538041 | |
| Pubmed | Hepatic lipase maturation: a partial proteome of interacting factors. | 7.27e-06 | 31 | 140 | 4 | 19136429 | |
| Pubmed | 7.50e-06 | 10 | 140 | 3 | 7906708 | ||
| Pubmed | 7.50e-06 | 10 | 140 | 3 | 12832005 | ||
| Pubmed | Transglutaminase Type 2 Regulates ER-Mitochondria Contact Sites by Interacting with GRP75. | 7.50e-06 | 10 | 140 | 3 | 30590033 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNB FLNC ERCC6 ACLY DHX40 NIPSNAP1 PHB2 YBX3 HNRNPA1 PAICS DDX50 ASNS SMU1 TXNDC9 METAP2 HSPA5 HSPA9 DYNC1I2 | 8.88e-06 | 1353 | 140 | 18 | 29467282 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | FLNB ACLY TIGD4 CSMD2 NDUFS2 PCDH17 SLC6A6 LOXHD1 CDH20 AGL ASNS BOD1L1 HSPA5 | 9.40e-06 | 736 | 140 | 13 | 29676528 |
| Pubmed | An ER translocon for multi-pass membrane protein biogenesis. | 1.03e-05 | 11 | 140 | 3 | 32820719 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNC WWP1 RPS6KA2 PIGG NPHP4 ITPR3 MYOF CELSR1 SLC12A4 SH3TC1 ADAMTS7 CDK13 NEK8 MICAL3 PC RAB11FIP3 | 1.04e-05 | 1105 | 140 | 16 | 35748872 |
| Pubmed | ZNF143 DHX40 TRPS1 CSMD2 HSPA12B STK31 PTER NDUFS2 ITPR3 DSG4 FER1L5 NOMO3 | 1.13e-05 | 638 | 140 | 12 | 31182584 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | FLNB FLNC ACLY DHX40 PHB2 HNRNPA1 PAICS LIG1 DDX50 XPO5 BOD1L1 PC HSPA5 HSPA9 RSBN1L | 1.16e-05 | 989 | 140 | 15 | 36424410 |
| Pubmed | FLNB ACLY PHB2 YBX3 PAICS XPO5 CDK13 ASNS TXNDC9 TACC3 HSPA5 HSPA9 DYNC1I2 IPO11 | 1.33e-05 | 878 | 140 | 14 | 37223481 | |
| Pubmed | FLNB FLNC ACLY YBX3 HNRNPA1 PAICS MRM3 ASNS SMU1 HSPA5 HSPA9 | 1.54e-05 | 551 | 140 | 11 | 34728620 | |
| Pubmed | Transcriptional regulation of the human asparagine synthetase gene by carbohydrate availability. | 1.61e-05 | 2 | 140 | 2 | 10085239 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 32960212 | ||
| Pubmed | siDirect: highly effective, target-specific siRNA design software for mammalian RNA interference. | 1.61e-05 | 2 | 140 | 2 | 15215364 | |
| Pubmed | Phosphorylation of hnRNP A1-Serine 199 Is Not Required for T Cell Differentiation and Function. | 1.61e-05 | 2 | 140 | 2 | 38334757 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 31346222 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 1406633 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 35314946 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 28220845 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 16329989 | ||
| Pubmed | The limits of promiscuity: isoform-specific dimerization of filamins. | 1.61e-05 | 2 | 140 | 2 | 12525170 | |
| Pubmed | Human proteoglycan testican-1 inhibits the lysosomal cysteine protease cathepsin L. | 1.61e-05 | 2 | 140 | 2 | 14511383 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 23341783 | ||
| Pubmed | The estrogen-responsive B box protein: a novel regulator of keratinocyte differentiation. | 1.61e-05 | 2 | 140 | 2 | 11919186 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 28912364 | ||
| Pubmed | hnRNP A1 dysfunction in oligodendrocytes contributes to the pathogenesis of multiple sclerosis. | 1.61e-05 | 2 | 140 | 2 | 36382566 | |
| Pubmed | A novel human actin-binding protein homologue that binds to platelet glycoprotein Ibalpha. | 1.61e-05 | 2 | 140 | 2 | 9694715 | |
| Pubmed | Differential effect of CLK SR Kinases on HIV-1 gene expression: potential novel targets for therapy. | 1.61e-05 | 2 | 140 | 2 | 21682887 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 34146477 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 31342168 | ||
| Pubmed | Two Hsp70 family members expressed in atherosclerotic lesions. | 1.61e-05 | 2 | 140 | 2 | 12552099 | |
| Pubmed | The E3 Ligase TRIM16 Is a Key Suppressor of Pathological Cardiac Hypertrophy. | 1.61e-05 | 2 | 140 | 2 | 35437018 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 31169879 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 32251645 | ||
| Pubmed | Regulation of mouse hepatitis virus RNA synthesis by heterogeneous nuclear ribonucleoprotein A1. | 1.61e-05 | 2 | 140 | 2 | 11774503 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 11774505 | ||
| Pubmed | HSP70s in Breast Cancer: Promoters of Tumorigenesis and Potential Targets/Tools for Therapy. | 1.61e-05 | 2 | 140 | 2 | 34943954 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 8041722 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 11535235 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 12560094 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLNB ACLY NIPSNAP1 PHB2 YBX3 PTER HNRNPA1 PAICS NDUFS2 MRM3 CDK13 AGL SMU1 PC METAP2 HSPA5 HSPA9 DYNC1I2 | 1.62e-05 | 1415 | 140 | 18 | 28515276 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | TMED1 FLNB FLNC GALC ZNF143 ACLY PHB2 NDUFS2 NOMO1 MRM3 LIG1 PTPRK NOMO2 AKR7A3 HSPA5 HSPA9 ADPGK NOMO3 | 2.26e-05 | 1451 | 140 | 18 | 30550785 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | FLNB FLNC ACLY YBX3 HNRNPA1 PAICS TRIM16 LIG1 XPO5 AGL ASNS PRKAR1B TXNDC9 METAP2 HSPA5 HSPA9 DYNC1I2 IPO11 | 2.34e-05 | 1455 | 140 | 18 | 22863883 |
| Pubmed | 2.70e-05 | 144 | 140 | 6 | 35681168 | ||
| Pubmed | ACLY DHX40 PHB2 YBX3 HNRNPA1L2 GTPBP1 HNRNPA1 PAICS NDUFS2 STK3 MRM3 ASNS SMU1 IFT80 PC HSPA5 HSPA9 | 2.80e-05 | 1335 | 140 | 17 | 29229926 | |
| Pubmed | 2.84e-05 | 484 | 140 | 10 | 31995728 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | ACLY DHX40 YBX3 HNRNPA1L2 HNRNPA1 PAICS DDX50 CLK1 ASNS SMU1 HSPA5 HSPA9 | 3.41e-05 | 714 | 140 | 12 | 28302793 |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 3.46e-05 | 91 | 140 | 5 | 28558017 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | TMED1 FLNB FLNC GTPBP1 HNRNPA1 PAICS NDUFS2 MYOF AGL ASNS TACC3 PC METAP2 HSPA5 HSPA9 DYNC1I2 IPO11 | 3.76e-05 | 1367 | 140 | 17 | 32687490 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | FLNB FLNC NIPSNAP1 PHB2 YBX3 HNRNPA1L2 HNRNPA1 NDUFS2 PRKAR1B BOD1L1 HSPA5 HSPA9 DYNC1I2 | 4.05e-05 | 847 | 140 | 13 | 35235311 |
| Pubmed | B3GALNT2 HNRNPA1 NDUFS2 NOMO1 SEMA4C NOMO2 TTC13 HSPA5 HSPA9 NOMO3 IPO11 | 4.07e-05 | 613 | 140 | 11 | 22268729 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 25901972 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 21454539 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 12906867 | ||
| Pubmed | PRMT5 regulates IRES-dependent translation via methylation of hnRNP A1. | 4.81e-05 | 3 | 140 | 2 | 28115626 | |
| Pubmed | The CLK family kinases, CLK1 and CLK2, phosphorylate and activate the tyrosine phosphatase, PTP-1B. | 4.81e-05 | 3 | 140 | 2 | 10480872 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 11252955 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 38320300 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 34620856 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 37525910 | ||
| Pubmed | HuR-regulated mRNAs associated with nuclear hnRNP A1-RNP complexes. | 4.81e-05 | 3 | 140 | 2 | 24152440 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 15390079 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 9021139 | ||
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 33692334 | ||
| Pubmed | The Splicing Factor hnRNPA1 Regulates Alternate Splicing of the MYLK Gene. | 4.81e-05 | 3 | 140 | 2 | 29077485 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 25762674 | ||
| Pubmed | Molecular cloning of the genes suppressed in RVC lymphoma cells by topoisomerase inhibitors. | 4.81e-05 | 3 | 140 | 2 | 8912629 | |
| Interaction | FGD5 interactions | 1.23e-05 | 207 | 137 | 9 | int:FGD5 | |
| Interaction | BRAF interactions | 1.49e-05 | 212 | 137 | 9 | int:BRAF | |
| Interaction | RYK interactions | 1.49e-05 | 212 | 137 | 9 | int:RYK | |
| Interaction | EEF2KMT interactions | 2.72e-05 | 26 | 137 | 4 | int:EEF2KMT | |
| Interaction | ARRDC2 interactions | 3.27e-05 | 54 | 137 | 5 | int:ARRDC2 | |
| Interaction | TSHR interactions | 4.96e-05 | 96 | 137 | 6 | int:TSHR | |
| Interaction | SLURP1 interactions | 5.83e-05 | 144 | 137 | 7 | int:SLURP1 | |
| Interaction | INVS interactions | 5.90e-05 | 99 | 137 | 6 | int:INVS | |
| Interaction | SAMD9L interactions | 6.46e-05 | 12 | 137 | 3 | int:SAMD9L | |
| Interaction | CKAP5 interactions | 7.22e-05 | 322 | 137 | 10 | int:CKAP5 | |
| GeneFamily | Heat shock 70kDa proteins | 1.98e-06 | 17 | 100 | 4 | 583 | |
| GeneFamily | Fibronectin type III domain containing | 2.99e-05 | 160 | 100 | 7 | 555 | |
| GeneFamily | CD molecules|Type II classical cadherins | 4.51e-05 | 13 | 100 | 3 | 1186 | |
| GeneFamily | CDC like kinases | 1.80e-04 | 4 | 100 | 2 | 480 | |
| GeneFamily | Ferlin family | 4.48e-04 | 6 | 100 | 2 | 828 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 8.30e-04 | 8 | 100 | 2 | 281 | |
| GeneFamily | Non-clustered protocadherins | 1.93e-03 | 12 | 100 | 2 | 21 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 2.64e-03 | 14 | 100 | 2 | 1095 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 3.87e-03 | 57 | 100 | 3 | 1179 | |
| GeneFamily | Cadherin related | 3.90e-03 | 17 | 100 | 2 | 24 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | COL6A6 SPOCK1 LRRC49 LAMA3 GRM1 CSMD2 GRM3 CSMD3 PCDH17 HSPA12A PTPRK VCAN PCDH19 ASNS KCNK2 DCLK3 PRKAR1B MICAL3 BOD1L1 EPHB1 | 1.82e-06 | 1106 | 140 | 20 | M39071 |
| Coexpression | GSE10325_BCELL_VS_MYELOID_UP | 1.13e-05 | 197 | 140 | 8 | M3081 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-07 | 186 | 140 | 8 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.55e-06 | 178 | 140 | 7 | b169aa5eaa51730daaec69c6bc58126be1592a50 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.61e-06 | 179 | 140 | 7 | 065a50952e8703fa07767beb6b73a090bf378ca6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-06 | 182 | 140 | 7 | 31efc06d6b073e8e341648207093e5f33c6f9183 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.87e-06 | 183 | 140 | 7 | 01ad18f198195ce341bae01a1c8c253cc4607766 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.87e-06 | 183 | 140 | 7 | 1464b5c4425e8776c4aeb4d2b560481d4bf13931 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.01e-06 | 185 | 140 | 7 | 87151ab95530e70d61328b336518df58db584acb | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-06 | 186 | 140 | 7 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.66e-06 | 193 | 140 | 7 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-06 | 195 | 140 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-06 | 195 | 140 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.04e-06 | 133 | 140 | 6 | 29b0c2c682c6b97823e7d8d8ba1f5114044b30ba | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.01e-05 | 156 | 140 | 6 | 2cd007b423c2395c5ce331902e7f27c805755eb3 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-05 | 166 | 140 | 6 | 30a991fc3275b571d53bd0976df4789e5d40b01d | |
| ToppCell | 368C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.44e-05 | 166 | 140 | 6 | 76b4cd32698900797ec009f17e50ea7ae36b85f4 | |
| ToppCell | ASK440-Immune-B_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.54e-05 | 168 | 140 | 6 | 127559d1a083c68cda9fce143afcc3eec168df17 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.59e-05 | 169 | 140 | 6 | 0c341f91dc21aaf92bead18d59684d11510502ce | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5+_undifferentiated_cell_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 170 | 140 | 6 | 45de83a2231208b8e1f21061d0b91644b4a3ba93 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.64e-05 | 170 | 140 | 6 | b5b47fe42617a4c2ebb49c8ed55db3926213a75a | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-05 | 173 | 140 | 6 | 4968712af1cca8c932abd3323631d7dcaffd4a66 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 173 | 140 | 6 | fbc8ed566ea36c39c258dd6b3823c82f5d6eb17f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.88e-05 | 174 | 140 | 6 | bc978a2148a0261a4f9d1ca5479b707e224566be | |
| ToppCell | ILEUM-inflamed-(3)_pDC|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.00e-05 | 176 | 140 | 6 | b9f847dd55703e413f3cd815eef5724fffaf13b3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.07e-05 | 177 | 140 | 6 | f30d757ee8db7e10d547498dab6560473c6ed7c0 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-05 | 177 | 140 | 6 | d6596a0b6fd146fefc27717c1a7dbaa3774cc644 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-05 | 179 | 140 | 6 | 445eeb0356d9fd894aa33dd9f45d893b21424149 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-05 | 179 | 140 | 6 | 01302505816f272243659e20d751b61a198a2fc0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.27e-05 | 180 | 140 | 6 | c6030e725e3d86d5d74a1676330c77ffeceb324f | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-non-classical_monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.34e-05 | 108 | 140 | 5 | 695ed3f8cf637d767a6d79b0309d5ee82dfd063f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.42e-05 | 182 | 140 | 6 | cc6f9d606a4f8717dc44928ceec2a257636043fd | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.42e-05 | 182 | 140 | 6 | 205d9ad1ea4b7adee8054496cdde46c9c401a19a | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 2.49e-05 | 183 | 140 | 6 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | myeloid-pDC|World / Lineage and Cell class | 3.08e-05 | 190 | 140 | 6 | 88c42779ce2f817d28e672d83f3f1158581edf73 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.26e-05 | 192 | 140 | 6 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-05 | 194 | 140 | 6 | f35f03412b596b6b570b377ba1a607409d984bb1 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.66e-05 | 196 | 140 | 6 | a7adc0e0baef261d0937e4e8351321d41beca82f | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.76e-05 | 197 | 140 | 6 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-05 | 198 | 140 | 6 | 22559b161e67b49fe8028bfaf861e069063599f5 | |
| ToppCell | (03)_KRT6B+|World / shred by cell type by condition | 3.98e-05 | 199 | 140 | 6 | 9feaf8649b3f68f30b8cb6b045a2caa2dd343c7f | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.98e-05 | 199 | 140 | 6 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.98e-05 | 199 | 140 | 6 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.10e-05 | 200 | 140 | 6 | 47791c93d03ee17c1ce17e27f075be4fc6f2590e | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.10e-05 | 200 | 140 | 6 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 4.10e-05 | 200 | 140 | 6 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-SLC17A7_IL15-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.10e-05 | 200 | 140 | 6 | 48fd48990a6833066be314dc5b66b90893f7ea8f | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Artery|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.10e-05 | 200 | 140 | 6 | 77ae679c35d3b9e2b620f34129f3a8d47e922c65 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.10e-05 | 200 | 140 | 6 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | critical-Myeloid-Non-resident_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.10e-05 | 200 | 140 | 6 | f9acaaba67af88b1a93d2ef46ceba7705f35de63 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.10e-05 | 200 | 140 | 6 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.10e-05 | 200 | 140 | 6 | f75d95376a340d467c4392b872b2a2dbdd184556 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.10e-05 | 200 | 140 | 6 | fae26560ba3b0b638b6bcf92f05330824b31d21b | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-SLC17A7_IL15--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.10e-05 | 200 | 140 | 6 | 9103e6f72a04f66f2b7069b0d71a719e9b10026b | |
| ToppCell | LPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type | 4.10e-05 | 200 | 140 | 6 | b17eb1587ca86c3d40515128a00a8d8fd787fccf | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.10e-05 | 200 | 140 | 6 | d31e26387d879ee30731c497cea6aaf4746e40d9 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.10e-05 | 200 | 140 | 6 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 4.10e-05 | 200 | 140 | 6 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-SLC17A7_IL15|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.10e-05 | 200 | 140 | 6 | e5e97767beb4413e87c9817a60a5f1ee5209198a | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.08e-05 | 140 | 140 | 5 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like-MAIT|blood / Manually curated celltypes from each tissue | 8.64e-05 | 142 | 140 | 5 | 1175d4390d204ffa3a2d2fe24486f85d3b639b72 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.08e-04 | 149 | 140 | 5 | d9c47f523c75ddcd6131e45d2ffc24b970932cae | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Col27a1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.27e-04 | 154 | 140 | 5 | d22902d2922784583f7016453768ed05b14b965e | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Agmat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.34e-04 | 156 | 140 | 5 | 09e0702400570089d9012dcf94dfb4827c97e49d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.39e-04 | 157 | 140 | 5 | 516903469756c5fabfdf56d7bd59b3bdd7b44e39 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.43e-04 | 158 | 140 | 5 | 3d6295fe25e3b1fb4b6e83704c5bdbf86dc639b3 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-04 | 158 | 140 | 5 | 91d265e95156f16459924d3e4dd11c180e164eee | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-3|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.47e-04 | 159 | 140 | 5 | fb222c42f66901852b01cec073ec0732245ee973 | |
| ToppCell | (04)_Pre-ciliated-(2)_48hpi|(04)_Pre-ciliated / shred by cell type and Timepoint | 1.47e-04 | 159 | 140 | 5 | e1f36b237e314ef6a18224eb8f3b97a612c39506 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.51e-04 | 160 | 140 | 5 | 04714d0b9bad4c11fa193ed168e2d84a4df39e2e | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.56e-04 | 161 | 140 | 5 | e3327c296d48e821004e61a573abb75624a6f040 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Brinp3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.65e-04 | 163 | 140 | 5 | b0aa4a620bd58011225b42ea6dda04e3101ba342 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-04 | 166 | 140 | 5 | 5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Alveolar_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.80e-04 | 166 | 140 | 5 | 65dafed953b01a9830b54309af75c7a561e88336 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.80e-04 | 166 | 140 | 5 | 36c443c9df9ed09fdede67df6f71eed1cca9cff1 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-04 | 166 | 140 | 5 | 6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-04 | 167 | 140 | 5 | a6ff7a3d9b80839c0efa91658836812e868561fa | |
| ToppCell | VE-Treg-exh_CD4|VE / Condition, Cell_class and T cell subcluster | 1.85e-04 | 167 | 140 | 5 | 1036ac1ef9440612500137af9d1929672b077e4d | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 1.90e-04 | 168 | 140 | 5 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | (3)_DC_plasmacytoid|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.90e-04 | 168 | 140 | 5 | 8a913db9b2a1a4ff96fb139734a3834e6aa263f1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.95e-04 | 169 | 140 | 5 | 1c9e54e7b14eb99996590fb93b257cf881a9f184 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.95e-04 | 169 | 140 | 5 | 716e9d4c5fb99c56b76afaa5ed90bfa859fde802 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.95e-04 | 169 | 140 | 5 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBC1D26|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.95e-04 | 169 | 140 | 5 | 2abdd8ae9a5d88aac30992142d1b502c959bc015 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 170 | 140 | 5 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 170 | 140 | 5 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-04 | 170 | 140 | 5 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.12e-04 | 172 | 140 | 5 | cecfe5cf20f317ea01b4604789e07a14481c4cd6 | |
| ToppCell | E12.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.12e-04 | 172 | 140 | 5 | ba99688e9f46671deccf824b1e77c6db0742d7df | |
| ToppCell | E12.5-Endothelial-proliferative_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.12e-04 | 172 | 140 | 5 | 2136170f6e1204734cec7dbf7b32e7d5179b92b5 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 2.23e-04 | 174 | 140 | 5 | b4f3f5334803e5903bc496decf923f2e44f7fa3c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_TBCC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.23e-04 | 174 | 140 | 5 | 912a9e892b29d945666fc37c986009c97c668ac8 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.23e-04 | 174 | 140 | 5 | 4120656e6d6cf5435a248326b5fdbdc7b22137af | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.23e-04 | 174 | 140 | 5 | d0e3d15731de6c19c232e3aa492c39d8151cf4ed | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.23e-04 | 174 | 140 | 5 | e4d65fe121a32ac4cdd6312e7b8f867f0852e991 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.23e-04 | 174 | 140 | 5 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-Tfh|blood / Manually curated celltypes from each tissue | 2.29e-04 | 175 | 140 | 5 | d7e24ac683ff36f7ce3d1151353d3d4a6f2b63bf | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.36e-04 | 176 | 140 | 5 | 0710689e66deba179b0a8038cdd56b4834984f12 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.36e-04 | 176 | 140 | 5 | 77516048aefbe1f48e825052756df0c310c1c486 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-04 | 176 | 140 | 5 | 2e9073166da4d9fae70ba4f3fdcad35523caf7cd | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.36e-04 | 176 | 140 | 5 | 96779273b94345250cf53ba671203345b43d9e00 | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.36e-04 | 176 | 140 | 5 | 27e6b3ae41068d6cfdda3d46da7df2a27567140e | |
| Drug | gadolinium | 4.16e-07 | 199 | 139 | 10 | CID000023982 | |
| Disease | myopathy (implicated_via_orthology) | 3.03e-06 | 48 | 138 | 5 | DOID:423 (implicated_via_orthology) | |
| Disease | myofibrillar myopathy 5 (implicated_via_orthology) | 6.49e-05 | 3 | 138 | 2 | DOID:0080096 (implicated_via_orthology) | |
| Disease | distal muscular dystrophy 4 (implicated_via_orthology) | 6.49e-05 | 3 | 138 | 2 | DOID:0111190 (implicated_via_orthology) | |
| Disease | Ciliopathies | 1.72e-04 | 110 | 138 | 5 | C4277690 | |
| Disease | cortical thickness | FLNB RPS6KA2 LRRC49 TRPS1 HNRNPA1L3 PCDH17 CELSR1 CDH20 ADAMTS7 XPO5 VCAN KCNK2 MICAL3 TACC3 CACNA2D3 | 2.32e-04 | 1113 | 138 | 15 | EFO_0004840 |
| Disease | limb-girdle muscular dystrophy (implicated_via_orthology) | 4.49e-04 | 7 | 138 | 2 | DOID:11724 (implicated_via_orthology) | |
| Disease | pneumococcal meningitis | 5.97e-04 | 8 | 138 | 2 | EFO_1001114 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 6.14e-04 | 145 | 138 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | Nephronophthisis | 7.65e-04 | 9 | 138 | 2 | cv:C0687120 | |
| Disease | ciliopathy (implicated_via_orthology) | 8.71e-04 | 40 | 138 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | asparagine measurement | 9.37e-04 | 41 | 138 | 3 | EFO_0009766 | |
| Disease | reaction time measurement | MYO1G ZFAT YBX3 STK31 HNRNPA1L3 PCDH17 TRIM16 PTPRK PC DYNC1I2 | 1.09e-03 | 658 | 138 | 10 | EFO_0008393 |
| Disease | brain measurement, neuroimaging measurement | DCHS2 TRPS1 RFTN2 HNRNPA1L3 VCAN KCNK2 CATSPERB TACC3 METAP2 | 1.17e-03 | 550 | 138 | 9 | EFO_0004346, EFO_0004464 |
| Disease | Gastric Adenocarcinoma | 1.23e-03 | 45 | 138 | 3 | C0278701 | |
| Disease | caudate nucleus measurement, functional brain measurement, response to reward | 1.40e-03 | 47 | 138 | 3 | EFO_0007849, EFO_0008387, EFO_0008396 | |
| Disease | Nephronophthisis | 1.64e-03 | 13 | 138 | 2 | C0687120 | |
| Disease | Colorectal Carcinoma | 1.76e-03 | 702 | 138 | 10 | C0009402 | |
| Disease | Colorectal Neoplasms | 1.98e-03 | 277 | 138 | 6 | C0009404 | |
| Disease | inherited metabolic disorder (is_implicated_in) | 2.19e-03 | 15 | 138 | 2 | DOID:655 (is_implicated_in) | |
| Disease | optic cup area measurement | 2.31e-03 | 56 | 138 | 3 | EFO_0006940 | |
| Disease | cathepsin L1 measurement | 2.50e-03 | 16 | 138 | 2 | EFO_0010619 | |
| Disease | food allergy measurement, parental genotype effect measurement | 3.16e-03 | 18 | 138 | 2 | EFO_0005939, EFO_0007016 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 3.52e-03 | 19 | 138 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | HIV-1 infection, Susceptibility to viral and mycobacterial infections | 4.30e-03 | 21 | 138 | 2 | EFO_0000180, Orphanet_391311 | |
| Disease | Infiltrating duct carcinoma of female breast | 4.30e-03 | 21 | 138 | 2 | C3165106 | |
| Disease | visceral:subcutaneous adipose tissue ratio | 4.36e-03 | 70 | 138 | 3 | EFO_0004767 | |
| Disease | neuroimaging measurement | DCHS2 LRRC49 TRPS1 HNRNPA1L3 CELSR1 VCAN KCNK2 PLD1 TACC3 PC METAP2 IPO11 | 4.48e-03 | 1069 | 138 | 12 | EFO_0004346 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IFSGEGSDELTQGYI | 361 | P08243 | |
| VDTVIGEGEFGEVYR | 626 | P21709 | |
| KGEYEVAEGIGSTVF | 211 | Q9BSF8 | |
| RVGVFLDYEGGTISF | 406 | Q6UXE8 | |
| TVGLGDAISAEGLFY | 476 | Q9BRR6 | |
| AFVYSEGQSETILGG | 46 | O95154 | |
| LGFIVDTIVDGVYIG | 196 | Q9H7T0 | |
| DTIVDGVYIGITFGG | 201 | Q9H7T0 | |
| FDLERGYDTLTVGDG | 451 | Q7Z408 | |
| LEIGYDTLTIGDGGE | 596 | Q7Z407 | |
| DGVVTVDDLRGVYSG | 196 | Q13938 | |
| ELVTTGHYGFTLGEE | 541 | P13611 | |
| ERYEIVSTLGEGTFG | 161 | P49760 | |
| VHVCGEGGEYETFTL | 196 | Q7L8W6 | |
| VASEGDYGETGIEAF | 216 | Q14832 | |
| GETIYVIGQGSDGTE | 91 | O00178 | |
| STDTVYDVVVSGGGL | 31 | Q9Y2Z9 | |
| DGDGDFYIEPTSGVI | 936 | Q9NYQ6 | |
| GEYVGKVFRVDAETG | 86 | P33151 | |
| KGDFYTLTVVADDGG | 1381 | Q9H251 | |
| VDPTEEYFVTGSAEG | 2936 | Q9Y485 | |
| SGGGVTPLVEYEDVS | 136 | Q14004 | |
| GGDGEVEEYLSFRSV | 36 | Q03468 | |
| SGTFEEAEGLGYVDV | 701 | Q9UKP4 | |
| YEIVDTLGEGAFGKV | 161 | P49759 | |
| IIVGFDDGSIGIYTV | 1631 | Q9ULI1 | |
| GFGFVTYATVEEVDA | 56 | Q32P51 | |
| GFGFVTYATVEEVDA | 11 | A0A2R8Y4L2 | |
| EGYVLTAVEGTIGDF | 856 | P69849 | |
| DFGESGRLTYEIVDG | 616 | O14917 | |
| SLEGFFIYEEEGSGV | 316 | Q52LD8 | |
| ITVIGGEEHFEDYGE | 381 | O75154 | |
| GDIVSLYAEGSVNGF | 11 | Q14573 | |
| GGDGEVEEYLSFRSV | 36 | P0DP91 | |
| GLVTVTGALDYEEGH | 296 | Q8TAB3 | |
| IEEVIGAGEFGEVYK | 621 | P54762 | |
| EIIETIGNGAYGVVS | 56 | Q13164 | |
| EGYVLTAVEGTIGDF | 856 | Q5JPE7 | |
| YVAGGLGETEDLLSF | 421 | A6NCF5 | |
| GEGTVVVSYGVSLEN | 256 | Q9NPJ1 | |
| VSEYEFEVIIGGDGR | 211 | Q7RTP6 | |
| EEGEVYAIETFGSTG | 356 | P50579 | |
| EKGIYFSEEGGHVVL | 3156 | Q16787 | |
| YDIIEVLGKGTFGEV | 11 | Q8NE63 | |
| TTGYEEAAAQGVIAG | 436 | Q9Y2Z2 | |
| ESYTVLGDTLIDGGE | 341 | Q9BTV5 | |
| LEFSVSYVFTEVGEG | 296 | Q9UI26 | |
| VVYEAGVFSVTAGDG | 446 | Q14117 | |
| VITLTTIGFGDYVAG | 261 | O95069 | |
| TIGFGDYVAGGSDIE | 266 | O95069 | |
| VKVYTGDVIGAGTDA | 176 | Q8IVV2 | |
| TYEIVIETGNGGETR | 1811 | Q8IVV2 | |
| EVIVTTGYEPGAGTD | 1951 | Q8IVV2 | |
| AVGDSEGQIVIYDVG | 586 | Q13409 | |
| YETGRVIGDGNFAVV | 356 | Q9C098 | |
| LDSGAAGIYTEDITG | 596 | Q86SJ6 | |
| TGTVRFDGYVIDGAT | 76 | Q9UK73 | |
| YLLTGEGAGTVFVID | 81 | Q86UP0 | |
| SDFIVDTRDAGYGGI | 2021 | O75369 | |
| REFEEVLAISGGIYG | 61 | Q8N8M0 | |
| YTAGAGTGDVAVVIV | 401 | Q14315 | |
| EGYVLTAVEGTIGDF | 856 | Q15155 | |
| GDAFTVAIGAESEVY | 621 | Q86SG6 | |
| FGLGEVDDKIYVVAG | 391 | O60662 | |
| VEVDGDTLSLYGSGA | 411 | Q8IUZ0 | |
| YVVVDSGGGTVDLTV | 311 | O43301 | |
| YVVADCGGGTVDLTV | 316 | Q96MM6 | |
| EDKVIAVYDLGGGTF | 236 | P38646 | |
| AVYDLGGGTFDISIL | 241 | P38646 | |
| AVAYGVRESVFTVEG | 31 | Q99623 | |
| GVVTAEEALNYGFSG | 276 | O75306 | |
| EDSFQVGGGETYTIG | 1376 | O75161 | |
| ETGVHIISGAGFYVD | 116 | Q96BW5 | |
| GDAAYFAVEELSGVV | 351 | Q6V1P9 | |
| DASTGEVRVIGGLDY | 311 | Q9Y5I4 | |
| TGLVGGSYDVLVSGE | 2001 | Q8NFC6 | |
| YEGTALVTVGEDGQI | 116 | Q9P2H3 | |
| SSEGYLEVGEGEQVT | 46 | Q96CJ1 | |
| YTQTGDFFGEIEGAV | 871 | Q8IZS8 | |
| YILSGEGAGIVFTID | 96 | Q9HBT6 | |
| EGVEGVAGGFIYTIQ | 266 | Q8NCR0 | |
| VAGGFIYTIQEGDAL | 271 | Q8NCR0 | |
| AVIGDVLQVYSGSEG | 376 | Q9BQ39 | |
| VIFGDLEYVTVEGGI | 171 | P0DN25 | |
| YEFRVVAGNSIGIGE | 671 | Q9UQ52 | |
| GEPGDDFYIITEGTA | 286 | P31321 | |
| TDSAEIRGLEGGVSY | 826 | Q02388 | |
| TAGKEVVYFVAGVGV | 31 | Q6ZMW3 | |
| EGIFDYAAAIGGATI | 106 | Q9BY41 | |
| VIEGYEVEANGGITI | 326 | Q13255 | |
| DVGTVVGIDLGTTYS | 26 | P11021 | |
| IGALLIGEEYGDVTF | 26 | Q96Q07 | |
| DGVGDTLDLVVIGAY | 751 | P18858 | |
| VYIETPDTGGVFIAG | 566 | P54803 | |
| SLTIDGIRYVVDGGF | 351 | Q8IX18 | |
| GGAIEEVYVSLGVSV | 386 | P07358 | |
| RQEGVIIYSVGVFGS | 746 | A6NMZ7 | |
| FVAAIDVYEDGEAGL | 701 | Q5VVW2 | |
| VIFEAEVSGGRSGYI | 166 | Q15262 | |
| EVSGGRSGYIAIDDI | 171 | Q15262 | |
| GYLVTKVVAVDGDSG | 581 | Q9Y5E3 | |
| EAVGGFFSQIGELYV | 216 | Q9BPW8 | |
| ISLVGAVDEEVGDYF | 466 | Q6PCB5 | |
| GGTSDAYAVIQVGKE | 36 | Q6WKZ4 | |
| QEGTTGVYTALGYVE | 181 | Q8N808 | |
| VLGTGAEVDYLEQFG | 531 | Q9Y6A5 | |
| FLEIIIGQYTSEGGI | 96 | P31641 | |
| STGEEIEGVYSGFLP | 416 | A0AVI2 | |
| AAVVIGGETYGVSLE | 351 | Q9HC36 | |
| DQSVAFVGGIDLAYG | 471 | Q13393 | |
| GFVGFVVGTYQALDE | 451 | Q495M3 | |
| VYFEEALGALEGSFG | 581 | Q8TE82 | |
| LDGATYTVLFIGTGD | 431 | Q9C0C4 | |
| IVGSVIQGSFLESYG | 726 | Q9UP95 | |
| IYFTLVTEGGGEIDF | 71 | Q9Y5J5 | |
| RTTDGVYEGVAIGGD | 676 | P53396 | |
| HGVLVVGYGFESTES | 276 | P07711 | |
| GTVIAQAEYGSVDIG | 186 | Q9BXU1 | |
| YEGDGIPTVFVAVAG | 316 | P22234 | |
| YGAFTGESLAAEIEG | 366 | O60296 | |
| YDVQVTSGGTFIGIG | 306 | Q9UHF7 | |
| VFDVLEKLGEGSYGS | 26 | Q13188 | |
| EYDGFTITITGDKVG | 686 | Q8NBP0 | |
| DVEGIETVTVYTQGG | 1201 | Q9P243 | |
| KGSQITYVTGVEGDD | 466 | P52747 | |
| YLRSVGDGETVEFDV | 131 | P16989 | |
| GQYLVTGSVDGFIEV | 226 | Q2TAY7 | |
| VGGTYELHVGDTIDL | 136 | Q9UNG2 | |
| GAGVEFPEGLSIEEY | 406 | Q8IY51 | |
| FGSGGSVVLLDDLEY | 386 | Q08629 | |
| LEEAKAGGFVVGYTS | 741 | Q9HAV4 | |
| LGSGAFGEVYEGTAV | 1951 | P08922 | |
| FGEVYEGTAVDILGV | 1956 | P08922 | |
| FGVVFSEAYADGIEG | 176 | Q9P1P5 | |
| IGVFGESVKGYGEVT | 156 | Q9BVV7 | |
| FEVEIFGAGTYVGLT | 431 | O95361 | |
| LETEYQVIGGAGLDV | 56 | Q13445 | |
| FGTAIYTEVVVDGEI | 36 | Q9H0M0 | |
| VDISAGFVGLDTYVE | 866 | Q5H8A4 | |
| GFGFVTYATVEEVDA | 56 | P09651 | |
| DGKTQDYVVGFTDLG | 151 | O14530 | |
| GFADGLGVAEAISYV | 516 | Q8NG27 | |
| AGGVVEAAISYTGDV | 696 | P11498 | |
| ILVDDGTVGKYGAEV | 246 | Q96QT4 | |
| EVEIFGAGTYVGLTC | 216 | Q309B1 | |
| NITAGVDEETGFVYG | 1236 | P35573 | |
| FTDGYEIKEDIGVGS | 411 | Q15349 | |
| GKDTVIGVLDIYGFE | 386 | B0I1T2 | |
| GQDTGATIDLVIGYD | 111 | Q9NZM1 |